The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Wit, D.
Right arrow Articles by Urbain, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Wit, D.
Right arrow Articles by Urbain, J.

The Journal of Immunology, Vol 150, Issue 2 361-366, Copyright © 1993 by American Association of Immunologists

ARTICLES

Preferential activation of Th2 cells in chronic graft-versus-host reaction

D De Wit, M Van Mechelen, C Zanin, JM Doutrelepont, T Velu, C Gerard, D Abramowicz, JP Scheerlinck, P De Baetselier and J Urbain
Departement de Biologie Moleculaire, Universite Libre de Bruxelles, Belgium.

The injection of DBA/2 parental lymphocytes into adult, immunologically intact (C57BL/6 x DBA/2) F1 hybrid mice results in a chronic graft-vs- host reaction (GVHR) characterized by a deficiency in CD4+ T cell functions and a B cell activation leading to autoantibody production. The discovery that distinct subpopulations of Th cells may regulate the effector immune functions led us to investigate whether the chronic GVHR differentially affects Th subsets. Data are presented indicating that mice undergoing a GVHR spontaneously produced lymphokines of Th2 origin. IL-4 and IL-10 mRNA were detected in the spleens of GVH mice, and IL-4 was shown to be responsible for the increased expression of class II Ag on B cells. Moreover, upon polyclonal activation in vitro, GVH T cells exhibited defective IL-2 and IFN-gamma production but elevated IL-4 production. We conclude that the chronic GVHR is characterized by a selective deficiency in cells secreting IL-2 and IFN- gamma and a hyperactivation of Th2 cells. The simultaneous production of IL-4 and IL-10 might explain the association between B cell hyperactivity and impairment of Th1-like activities in various models that associate autoimmunity and immunosuppression, such as GVHR and HIV infection.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
A. Giorgini and A. Noble
Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts
J. Leukoc. Biol., November 1, 2007; 82(5): 1053 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Hurchla, J. R. Sedy, and K. M. Murphy
Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation
J. Immunol., May 15, 2007; 178(10): 6073 - 6082.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kim, W. S. Choi, H. Kang, H. J. Kim, J.-H. Suh, S. Sakaguchi, and B. Kwon
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
J. Immunol., May 1, 2006; 176(9): 5223 - 5231.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. R. Chevrier, A. E. Ryan, D. Y.-W. Lee, M. Zhongze, Z. Wu-Yan, and C. S. Via
Boswellia carterii Extract Inhibits TH1 Cytokines and Promotes TH2 Cytokines In Vitro
Clin. Vaccine Immunol., May 1, 2005; 12(5): 575 - 580.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. M. Rigby, T. Rouse, and E. H. Field
Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells
Blood, March 1, 2003; 101(5): 2024 - 2032.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
D. G. Maloney, B. M. Sandmaier, S. Mackinnon, and J. A. Shizuru
Non-Myeloablative Transplantation
Hematology, January 1, 2002; 2002(1): 392 - 421.
[Abstract] [Full Text]

Home page
 BloodHome page
J. Liu, B. E. Anderson, M. E. Robert, J. M. McNiff, S. G. Emerson, W. D. Shlomchik, and M. J. Shlomchik
Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease
Blood, December 1, 2001; 98(12): 3367 - 3375.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Nozawa, J. Ohata, J. Sakurai, H. Hashimoto, H. Miyajima, H. Yagita, K. Okumura, and M. Azuma
Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases
J. Immunol., November 1, 2001; 167(9): 4981 - 4986.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. B. Vogelsang
How I treat chronic graft-versus-host disease
Blood, March 1, 2001; 97(5): 1196 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Tschetter, E. Mozes, and G. M. Shearer
Progression from Acute to Chronic Disease in a Murine Parent-into-F1 Model of Graft-Versus-Host Disease
J. Immunol., November 15, 2000; 165(10): 5987 - 5994.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
V. Moulin, F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, and M. Moser
B Lymphocytes Regulate Dendritic Cell (DC) Function In Vivo: Increased Interleukin 12 Production by DCs from B Cell-deficient Mice Results in T Helper Cell Type 1 Deviation
J. Exp. Med., August 14, 2000; 192(4): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Krenger, S. Rossi, L. Piali, and G. A. Hollander
Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells
Blood, July 1, 2000; 96(1): 347 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto
IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice
J. Immunol., June 1, 2000; 164(11): 6067 - 6074.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Sakurai, J. Ohata, K. Saito, H. Miyajima, T. Hirano, T. Kohsaka, S. Enomoto, K. Okumura, and M. Azuma
Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells
J. Immunol., January 15, 2000; 164(2): 664 - 669.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Okubo, E. Hagiwara, S. Ohno, T. Tsuji, A. Ihata, A. Ueda, A. Shirai, I. Aoki, K. Okuda, J.-i. Miyazaki, et al.
Administration of an IL-12-Encoding DNA Plasmid Prevents the Development of Chronic Graft-Versus-Host Disease (GVHD)
J. Immunol., April 1, 1999; 162(7): 4013 - 4017.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. Beland, H. Adler, N. C. Del-Pan, W. Kozlow, J. Sung, W. Fanslow, and I. J. Rimm
Recombinant CD40L Treatment Protects Allogeneic Murine Bone Marrow Transplant Recipients From Death Caused by Herpes Simplex Virus-1 Infection
Blood, December 1, 1998; 92(11): 4472 - 4478.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Meyers, J. E. Tomaszewski, J. D. Glass, and C. W. Chen
The Nephritogenic T Cell Response in Murine Chronic Graft-Versus-Host Disease
J. Immunol., November 15, 1998; 161(10): 5321 - 5330.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
J. Ferrara, K. Cooke, L Pan, and W Krenger
The immunopathophysiology of acute graft-versus-host-disease
Stem Cells, September 1, 1996; 14(5): 473 - 489.
[Abstract]

Home page
 LupusHome page
F. Houssiau, C. Lefebvre, M. Vanden Berghe, M. Lambert, J-P. Devogelaer, and J-C. Renauld
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
Lupus, October 1, 1995; 4(5): 393 - 395.
[Abstract] [PDF]

Home page
 LupusHome page
H. Yoshii, K. Yamamoto, H. Okudaira, M. Dohi, M. Suko, Y. Fukata, H. Yago, S. Suehiro, and K. Ito
Age-related differential mRNA expression of T cell cytokines in NZB/NZW F1 mice
Lupus, June 1, 1995; 4(3): 213 - 216.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.